Tesa
Tesamorelin is a GHRH analog studied for reducing abdominal fat in HIV patients.
Description
Tesamorelin is a GHRH analog FDA-approved for reducing visceral adiposity in HIV-infected patients with lipodystrophy.
It has also shown promise in improving lipid profiles and cognitive performance in aging populations.
– **FDA-approved for HIV lipodystrophy:** Falutz et al., 2007 [PMID: 17327290]
– **Neurocognitive benefits:** Stanley et al., 2016 [PMID: 27882781]
Reviews
There are no reviews yet.